University of Hertfordshire

From the same journal

Exploring the baseline knowledge and experience of healthcare professionals in the United Kingdom on Novel Psychoactive Substances
Research output: Contribution to journal › Article
The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
Research output: Contribution to journal › Editorial
Focus on clozapine withdrawal- and misuse-related cases, as reported to the European Medicines Agency (EMA) pharmacovigilance database
Research output: Contribution to journal › Article
Common and Distinct Functional Brain Networks for Intuitive and Deliberate Decision Making
Research output: Contribution to journal › Article

By the same authors

Substance Related Exogenous Psychosis: a post-modern syndrome
Research output: Contribution to journal › Article
Piloting the UK's First Home-Office-Licensed Pharmacist-Led Drug Checking Service at a Community Substance Misuse Service
Research output: Contribution to journal › Article
COVID-19: The hidden impact on mental health and drug addiction
Research output: Contribution to journal › Article
BEYOND THE PURPLE DRANK. STUDY OF PROMETHAZINE ABUSE ACCORDING TO THE EUROPEAN MEDICINES AGENCY (EMA) ADVERSE DRUG REACTIONS (ADR) REPORTS.
Research output: Contribution to journal › Article
Psychobiological; medical; and psychiatric implications of new/novel psychoactive substance (NPS) use
Research output: Chapter in Book/Report/Conference proceeding › Chapter

Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects

Research output: Contribution to journal › Editorial

Documents

brainsci-10-00146
Final published version, 187 KB, PDF document

Fabrizio Schifano

View graph of relations

Original language	English
Article number	146
Number of pages	4
Journal	Brain Sciences
Volume	10
Issue	3
DOIs	https://doi.org/10.3390/brainsci10030146
Publication status	Published - 4 Mar 2020

Abstract

New/novel psychoactive substances (NPS) are defined as new narcotic/psychotropic drugs which are not controlled by the United Nations' 1961 Narcotic Drugs/1971 Psychotropic Substances conventions, but which may pose a public health threat [...].

Notes

© 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

ID: 20709850